Name | 7-nitrospiro[2,3-dihydro-1H-isoquinoline-4,1'-cyclopropane] |
---|---|
Synonyms |
7-nitro-4-spiro-1'-cyclopropane-1,2,3,4-tetrahydro-isoquinoline
7'-nitro-2',3'-dihydro-1' H-spiro[cyclopropane-1,4'-isoquinoline] Spiro[cyclopropane-1,4'(1'H)-isoquinoline],2',3'-dihydro-7'-nitro 7'-nitro-1',2'-dihydro-3'h-spiro[cyclopropane-1,4'-isoquinoline] |
Molecular Formula | C11H12N2O2 |
---|---|
Molecular Weight | 204.22500 |
Exact Mass | 204.09000 |
PSA | 57.85000 |
LogP | 2.58160 |
HS Code | 2933499090 |
---|
~% 561297-87-8 |
Literature: MERCK and CO., INC.; BANYU PHARMACEUTICAL CO., LTD. Patent: WO2009/151997 A1, 2009 ; Location in patent: Page/Page column 27 ; WO 2009/151997 A1 |
~% 561297-87-8 |
Literature: Amgen Inc. Patent: US2003/225106 A1, 2003 ; Location in patent: Page 91 ; |
~% 561297-87-8 |
Literature: MERCK SHARP and DOHME CORP.; SHUMWAY, Stuart Denham; TONIATTI, Carlo; ROBERTS, Brian Scott; MARTIN, Melissa M. Patent: WO2013/39854 A1, 2013 ; |
Precursor 3 | |
---|---|
DownStream 0 |
HS Code | 2933499090 |
---|---|
Summary | 2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |